Ulla Grove Krogsgaard Thomsen
Ulla Grove Krogsgaard Thomsen holds a M.Sc. in Pharmaceutical Sciences from 1992 and a Ph.D. in Structural and Analytical chemistry from 1996, both obtained at University of Copenhagen. Dr. Thomsen joined Novo Nordisk Pharmatech A/S in 2021 as the CEO. Since 2019 she has been a member of the Bord of Directors. Dr. Thomsen joined […]
Christian Brøgger Stolberg
Christian Brøgger Stolberg holds a Master of Science (MSc) in Medicine with Industrial Specialisation / Biomedicine. Mr Stolberg joined Novo Nordisk Pharmatech in 2017 as a QA professional. In 2021 he joined production support as process responsible for the enzymes purification process in F8/F11. Mr Stolberg joined the KNSF in 2023 where he is currently […]
Joachim Hagemeister
Joachim Hagemeister joined Novo Nordisk Pharmatech A/S in 2012 as an operator specialised in clean room and aseptic production. Since 2016 he has been a member of the Bord of Directors. Mr. Hagemeister joined Novo Nordisk A/S in 2001 and has been working with Glucagon in Gentofte, inspection of penfill and vials plus aseptic filling […]
Jacob Sten Petersen
Jacob Sten Petersen has been Senior Vice President as Head of Global Nucleic Acid Therapies since 2023, responsible for RNAi modality and gene editing modality platform. He joined the Board of Directors of Novo Nordisk Pharmatech A/S in 2021. Mr. Petersen joined Novo Nordisk in 2001 as CVP for Global Research Metabolic Diseases and Adjunct Professor. In […]
Julie Aunbirk
Julie Aunbirk has been with NNE for more than 23 years and has, since July 2022, been heading up NNE’s largest area, covering all Engineering disciplines within Process & Facility Design. Since 2008, Ms Aunbirk has held various line management positions within Process & Utility, Mechanical, Instrumentation, and Validation. Furthermore, Ms Aunbirk was responsible for […]
Jean Fabian Jeldorf
Jean Fabian Jeldorf holds a M.Sc. in Auditing & Accounting (cand.merc.aud) from 2000 obtained at Copenhagen Business School.Mr. Jeldorf joined the Board of Directors in Novo Nordisk Pharmatech A/S in 2020 as Chairman. Mr. Jeldorf has worked in the auditing industry from 1996 to 2002. In 2002 he joined Novo Nordisk A/S. In the last […]
Tue Micheelsen
Tue Micheelsen is an accomplished commercial executive with over 20 years of experience in the biotech industry. He holds an M.Sc. in economics from Copenhagen Business School and concluded leadership and board education programs from Harvard Business School and INSEAD. Mr. Micheelsen joined Novozymes in 2003. In his various executive roles, he has been instrumental […]
